切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (06) : 493 -496. doi: 10.3877/cma.j.issn.2095-3232.2019.06.007

所属专题: 文献

临床研究

术前断流术及消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响
蔡秋程1, 蔡思奕1, 阮清1, 杨芳1, 江艺1,()   
  1. 1. 350025 解放军联勤保障部队第九〇〇医院肝胆外科
  • 收稿日期:2019-07-18 出版日期:2019-12-10
  • 通信作者: 江艺
  • 基金资助:
    福建省自然科学基金面上项目(2016J01585)

Effect of preoperative devascularization and impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients

Qiucheng Cai1, Siyi Cai1, Qing Ruan1, Fang Yang1, Yi Jiang1,()   

  1. 1. Department of Hepatobiliary Surgery, the 900th Hospital of PLA Joint Logistics Support Force, Fuzhou 350025, China
  • Received:2019-07-18 Published:2019-12-10
  • Corresponding author: Yi Jiang
  • About author:
    Corresponding author: Jiang Yi, Email:
引用本文:

蔡秋程, 蔡思奕, 阮清, 杨芳, 江艺. 术前断流术及消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 08(06): 493-496.

Qiucheng Cai, Siyi Cai, Qing Ruan, Fang Yang, Yi Jiang. Effect of preoperative devascularization and impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(06): 493-496.

目的

探讨术前断流术和消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响。

方法

回顾性分析2005年1月至2015年12月在解放军联勤保障部队第九○○医院行肝移植的110例肝硬化门静脉高压症患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男84例,女26例;年龄7~75岁,中位年龄46岁。根据术前有无断流术史和消化道出血史,将患者分为断流组(19例),非断流组(91例)及出血组(66例),非出血组(44例)。分析术前断流术及消化道出血对患者预后的影响。两组术中出血量、输液量等比较采用t检验,率的比较采用χ2检验。

结果

断流组患者术后并发症发生率和5年累积生存率分别为42%、74%,明显高于非断流组的19%、88%(χ2=4.91,2.56;P<0.05)。断流组术中出血量、输液量、手术时间、住院费用分别为(4 135±2 696)ml、(11 068±3 461)ml、(511±126)min、(28±9)万元,明显高于非断流组的(3 202±1 122)ml、(7 275±2 346)ml、(396±85)min、(24±5)万元(t=2.46,6.36,4.90,2.71;P<0.05)。出血组和非出血组上述指标比较,差异均无统计学意义(P>0.05)。

结论

术前断流术增加肝硬化门静脉高压症患者肝移植的难度,术后风险高,而消化道出血对肝移植疗效无明显影响。

Objective

To evaluate the effect of preoperative devascularization and the impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients.

Methods

Clinical data of 110 patients with cirrhotic portal hypertension undergoing liver transplantation in the 900th Hospital of PLA Joint Logistics Support Force from January 2005 to December 2015 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 84 patients were male and 26 female, aged 7-75 years with a median of 46 years. According to the history of preoperative devascularization and gastrointestinal hemorrhage, the patients were divided into the devascularization (n=19) and non-devascularization (n=91) groups, hemorrhage (n=66) and non-hemorrhage groups (n=44). The effect of preoperative devascularization and gastrointestinal hemorrhage on prognosis of patients was evaluated. Intraoperative blood loss and infusion volume between two groups were compared by t test. The rate comparison was performed by Chi-square test.

Results

The incidence of postoperative complications and the 5-year cumulative survival rate in devascularization group were 42% and 74%, significantly higher than 19% and 88% in non-devascularization group (χ2=4.91, 2.56; P<0.05). In devascularization group, intraoperative blood loss, infusion volume, operation time and hospitalization expense were (4 135±2 696) ml, (11 068±3 461) ml, (511±126) min, (280±90)×103 Yuan, respectively, significantly higher than (3 202±1 122) ml, (7 275±2 346) ml, (396±85) min, (240±50)×103 Yuan in non-devascularization group (t=2.46, 6.36, 4.90, 2.71; P<0.05). No significant difference was observed between the hemorrhage and non-hemorrhage groups (all P>0.05).

Conclusions

Preoperative devascularization increases the difficulty of liver transplantation for cirrhotic portal hypertension patients and yields high postoperative risk. Nevertheless, gastrointestinal hemorrhage exerts no significant impact upon the efficacy of liver transplantation.

表1 断流组和非断流组肝硬化门静脉高压症患者肝移植术中和术后情况比较
表2 出血组和非出血组肝硬化门静脉高压症患者肝移植术中和术后情况比较
[1]
刘斌,方正亚,孟冬梅.肝硬化并发症及预防研究进展[J].中华实用诊断与治疗杂志,2016, 30(12):1152-1155.
[2]
严律南.肝硬变门脉高压的肝脏移植经验[J].中国普外基础与临床杂志,2001, 8(4):263-264.
[3]
中华医学会传染病与寄生虫学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000, 8(6):324-329.
[4]
中华消化内镜学会.食管胃底静脉曲张内镜下诊断和治疗规范试行方案[J].中华消化内镜杂志,2000, 17(4):198-199.
[5]
中华医学会外科学分会门静脉高压学组.肝硬化门静脉高压食管、胃底静脉曲张破裂出血的诊治共识(2015版)[J].中华外科杂志,2015, 53(12):917-921.
[6]
程远,蔡秋程,江艺.下腔静脉逆行再灌注法在原位肝移植中的应用进展[J].器官移植,2016, 7(6):479-483.
[7]
Orozco H, Mercado MA, Chan C, et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers transendoscopicselerotherapy and surgery. a prospective, controlled, and randomized trial during 10 years[J]. Ann Surg, 2000, 232(2):216-219.
[8]
宋维平,杨长青.2016年美国肝病学会肝硬化门静脉高压出血的风险分层、诊断和管理实践指导[J].上海大学学报,2018, 24(3): 336-340.
[9]
Vorobioff JD, Groszmann RJ. Prevention of portal hypertension: from variceal development to clinical to decompensation[J]. Hepatology, 2015, 61(1):375-381.
[10]
Gareia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis[J]. N Engl J Med, 2010, 362(9):823-832.
[11]
Loren L. Primary prophylaxis of esophageal variceal bleeding: anendoscopic approach[J]. Hepatology, 2010, 52(6):944-945.
[12]
Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polyterafluoroethylene-covered stent: results of an Italian multi-center study[J]. Am J Roentgenol, 2005, 185(2):472-480.
[13]
Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant[J]. HPB, 2014, 16(5):481-493.
[14]
潘洪旭.肝硬化门静脉高压症合并上消化道出血患者的临床治疗研究[J].中国医药指南,2015, 13(1):116-117.
[15]
Unger LW, Berlakovich G, Trauner M, et al. Management of portal hypertension before and after liver transplantation[J]. Liver Transpl, 2018, 24(1):112-121.
[16]
霍枫,陈建雄,郑于剑,等.肝移植治疗门静脉高压症的作用与地位及需要注意的问题[J].中华消化外科杂志,2018, 17(10):976-980.
[17]
李铁汉,唐波,田大广,等.脾切除术后门静脉系统血栓形成的临床分析[J].腹部外科,2010, 23(6):341-343.
[18]
Jonathan GS, Puja MS, Scott LC, et al. Portal vein thrombosis, morality and hepatic decompensation in patients with cirrhosis:a meta-analysis[J]. World J Hepatol, 2015, 7(27):2774-2780.
[19]
蔡秋程,吕立志,陈少华,等.肝移植术中供肝门静脉与受体结肠中动脉吻合并脾切除一例[J].中华器官移植杂志,2009, 30(6): 382.
[20]
Lai JC, Dodge JL, Sen S, et al. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study[J]. Hepatology, 2016, 63(2): 574-580.
[1] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[2] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[5] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[6] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[8] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[9] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[10] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[11] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[12] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[14] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[15] 张红君, 郑博文, 廖梅, 任杰. 超声及超声造影在肝移植术后上腹部淋巴结良恶性鉴别诊断中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 562-567.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?